• call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:







    captcha

  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

Tamoxifen Produces Positive Results in Premenopausal Breast Cancer Patients

For the estimated 246,000 American women likely to be diagnosed with breast cancer this year, treatment may take on a variety of forms. Surgery, be it a lumpectomy or mastectomy, is almost always a given. Chemotherapy and radiation, too, may also be advised. Some women may also find their healthcare providers strongly urging the use of a medication known as tamoxifen.

This hormone therapy is generally used after surgery when breast cancer has been diagnosed. For some women, its use may prove extremely beneficial in prolonging life, recent research has found.

A long-term study into the effects of adjuvant tamoxifen on preventing mortality in breast cancer patients showed extremely positive results. In women with estrogen receptor positive primary breast cancer, this drug’s use was shown to significantly extended survival chances over the course of several decades.

The study involved more than 560 women who met the cancer criteria. Roughly half were treated with tamoxifen for two years following other treatments. The other half did not receive the drug. At a median follow-up of 26 years, the women in the adjuvant tamoxifen group had a decreased cancer-mortality rate over their counterparts, the study found. It is important to note though that during the first few years, all ER-positive patients had a high fatality rate. That rate declined by nearly 50 percent as time of follow up progressed for the tamoxifen patients.

Introducing tamoxifen into the adjuvant care routine for some breast cancer patients may result in improved outcomes. This drug, however, does come with its own share of potential side effects. Women who have been diagnosed with estrogen receptor positive breast cancer should carefully consider all their treatment options based on the particulars of their case and their doctor recommendations. Tamoxifen may help improve survival chances in some cases, but it is not a guarantee.

For the estimated 246,000 American women likely to be diagnosed with breast cancer this year, treatment may take on a variety of forms. Surgery, be it a lumpectomy or mastectomy, is almost always a given. Chemotherapy and radiation, too, may also be advised. Some women may also find their healthcare providers strongly urging the use of a medication known as tamoxifen.

This hormone therapy is generally used after surgery when breast cancer has been diagnosed. For some women, its use may prove extremely beneficial in prolonging life, recent research has found.

A long-term study into the effects of adjuvant tamoxifen on preventing mortality in breast cancer patients showed extremely positive results. In women with estrogen receptor positive primary breast cancer, this drug’s use was shown to significantly extended survival chances over the course of several decades.

The study involved more than 560 women who met the cancer criteria. Roughly half were treated with tamoxifen for two years following other treatments. The other half did not receive the drug. At a median follow-up of 26 years, the women in the adjuvant tamoxifen group had a decreased cancer-mortality rate over their counterparts, the study found. It is important to note though that during the first few years, all ER-positive patients had a high fatality rate. That rate declined by nearly 50 percent as time of follow up progressed for the tamoxifen patients.

Introducing tamoxifen into the adjuvant care routine for some breast cancer patients may result in improved outcomes. This drug, however, does come with its own share of potential side effects. Women who have been diagnosed with estrogen receptor positive breast cancer should carefully consider all their treatment options based on the particulars of their case and their doctor recommendations. Tamoxifen may help improve survival chances in some cases, but it is not a guarantee.

Cancer Screening Guidelines

Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

Learn More

Save Your Hair During Chemo

We offer the Chemo Cold Caps Solution for patients seeking to save their hair while undergoing chemotherapy.  The Chemotherapy Cold Caps program can be accessed at any of our North Texas clinics. At Choice Cancer Care we know that being diagnosed with...

Learn More

Learn About Your Options

Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

Learn More